PFM Health Sciences’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-92,236
| Closed | -$3.09M | – | 77 |
|
|
2025
Q1 | $3.09M | Sell |
92,236
-24,762
| -21% | -$831K | 0.22% | 46 |
|
|
2024
Q4 | $4.59M | Sell |
116,998
-62,880
| -35% | -$2.46M | 0.28% | 47 |
|
|
2024
Q3 | $7.08M | Buy |
179,878
+29,324
| +19% | +$1.15M | 0.4% | 45 |
|
|
2024
Q2 | $5.87M | Hold |
150,554
| – | – | 0.29% | 51 |
|
|
2024
Q1 | $6.48M | Sell |
150,554
-42,302
| -22% | -$1.82M | 0.3% | 60 |
|
|
2023
Q4 | $8.88M | Buy |
192,856
+114,269
| +145% | +$5.26M | 0.53% | 46 |
|
|
2023
Q3 | $2.68M | Sell |
78,587
-21,560
| -22% | -$736K | 0.13% | 65 |
|
|
2023
Q2 | $3.86M | Hold |
100,147
| – | – | 0.15% | 68 |
|
|
2023
Q1 | $3.58M | Buy |
100,147
+82,659
| +473% | +$2.96M | 0.16% | 62 |
|
|
2022
Q4 | $690K | Buy |
+17,488
| New | +$690K | 0.02% | 72 |
|